Searched for
JB PHARMA NEW
Capitalmind Flexi Cap Fund adds Nestle India and 10 others, exits SBI and 14 others in MayCapitalmind Flexi Cap Fund made significant portfolio adjustments in May. The fund welcomed Nestle India and eleven new stocks. It also div...- Two Trades for Today: 2 pharma companies – a large-cap for a 5% rise, and a mid-cap stock for a gain of 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Dividends, bonus issues: TCS, LIC, Bajaj Auto among 30 stocks turning ex-date this week. Check detailsInvestors must hold shares of these companies in their demat accounts on the record date to be eligible for the respective corporate action...
- Jio Financial, ITC Hotels and Manappuram Finance among stocks bought and sold by mutual funds in AprilMutual funds injected Rs 30,600 crore into Indian equities in April, with significant buying in ICICI Bank, SBI, and Sun Pharma. Key reduct...
- Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...
- ET Family Business Awards: Torrent Pharma drives growth through acquisitions and innovationAman Mehta is guiding Torrent Pharmaceuticals through a significant period of growth and strategic change. He is driving the company's expa...
- CCI clears Torrent Pharma's proposal to buy stake in JB ChemicalsIndia's competition regulator CCI has approved Torrent Pharmaceuticals' acquisition of a stake in JB Chemicals and Pharmaceuticals. This de...
- Torrent Pharma seeks CCI nod to acquire majority stake in JB Chemicals for Rs 19,500 crTorrent Pharmaceuticals is set to acquire a majority stake in J B Chemicals and Pharmaceuticals for Rs 19,500 crore, pending CCI approval. ...
- Torrent Pharma to acquire additional 2.41% stake in JB Chemicals for Rs 620 croreTorrent Pharmaceuticals is set to acquire an additional 2.41% stake in J.B. Chemicals & Pharmaceuticals from a group of employees for Rs 62...
- Torrent Pharma set to finalise JB Chemicals buyout in 15-18 monthsTorrent Pharmaceuticals is set to acquire JB Chemicals & Pharmaceuticals, with the deal expected to finalize in 15-18 months, pending regul...
- Torrent expects JB Chemicals acquisition deal to close in 15–18 monthsTorrent Pharmaceuticals is set to acquire a major stake in J B Chemicals. The deal is expected to finalize in 15 to 18 months. This acquisi...
- Torrent Pharma to buy controlling stake in JB Chemicals from KKRTorrent Pharmaceuticals is set to acquire a 46.39% controlling stake in JB Chemicals and Pharmaceuticals from KKR for ₹11,917 crore, valuin...
- Torrent Pharma to acquire JB Chemicals at Rs 25,689 crore valuationTorrent Pharma will acquire a controlling stake in JB Chemicals from KKR. The deal values JB Chemicals at Rs 25,689 crore. This merger will...
- Torrent Pharma closes in on JB Chem likely for $2.4 bn buyout, eyes $1.6 billion financingTorrent Pharma is in advanced talks with KKR to acquire JB Chemicals and Pharmaceuticals, reviving discussions from last year. The deal inv...
- JB Pharma Q1 Results: Net profit jumps 25% YoY to Rs 177 croreThe drug maker had reported a net profit of Rs 142 crore in the year-ago period.Revenue for the quarter rose 12% YoY to Rs 1004 crore
- JB Pharma expects India business to grow above market growth rate in FY25: CEO Nikhil ChopraJB Pharma, led by CEO Nikhil Chopra, forecasts 12-14% revenue growth and aims to increase Ebitda margins by 27-28% in FY25. The growth is d...
- JB Pharma inks Rs 1,089 cr pacts with Novartis for select ophthalmology brandsThe board of directors at its meeting held on December 19, 2023 approved the execution of a trade mark licence agreement with Novartis Inno...
- Jefferies initiates coverage on JB Pharma with a 'buy' tag; stock hits 52-week highJefferies has given a target of Rs 2,680 to JB Pharmaceuticals,respectively based on 20x June-25 EV-EBITDA valuations, due to its dominance...
- JB Pharma bets big on chronic therapy for its growth aspirationsJB Chemicals & Pharmaceuticals is keen to explore new opportunities in the world of metabolics and improve its own chronic contribution to ...
- KKR to buy 54% stake in JB Chemicals for Rs 3,100 croreThe stock has appreciated 60% in the past three months in anticipation of a transaction.
Load More
